Nasal Drug Delivery Market to Exhibit 7.3% CAGR; Increasing Prevalence of Asthma and COPD will Drive Market, projects Fortune Business Insights™

June 02, 2020 03:59 ET

             | Source:  Fortune Business Insights








        Pune, June  02, 2020  (GLOBE NEWSWIRE) -- The global Nasal Drug Delivery Market size is prognosticated to reach USD 73.84 billion by 2026 attributable to the increasing number of the patient population and the rising prevalence of pulmonary disorders worldwide. This information is provided in a recently published report by Fortune Business Insights™ titled, “Nasal Drug Delivery Market Size, Share and Global Trend By Type (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Regional Forecast, 2019-2026.” As per the report’s description, the market size was USD 42.38 billion in 2018 and is likely to exhibit a CAGR of 7.3% between 2019 to 2026.    Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nasal-drug-delivery-market-100415  What are the Key Objectives of this Report?  The report provides a comprehensive overview of the market for nasal drug delivery and its various growth parameters. These include factors driving, challenging, and providing opportunities to the market. Besides this, the report discusses the competitive landscape and lists the names of players operating in the market and the major strategies adopted by them. Adoption of different strategies will help key players to strive for the leading position in the market. It also discusses the key segments in the market based on factors such as type, application, end user, distribution channel, and others. Additionally, the report provides insights into the market, major industry developments, and current Nasal Drug Delivery Market trends. It is available for sale on the company website.  An Overview of the Impact of COVID-19 on this Market:  The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.  We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.  To get the short-term and long-term impact of COVID-19 on this Market.  Please visit: https://www.fortunebusinessinsights.com/industry-reports/nasal-drug-delivery-market-100415  Market Drivers:Rising Awareness About Nasal Drug Delivery and its Benefits will Help Market Gain Impetus  The increasing prevalence of respiratory disorders among people is a major factor boosting this market growth. Additionally, the increasing prevalence of asthma and chronic obstructive pulmonary disease (COPD) cases is also aiding to the expansion of the market for pulmonary drug delivery devices. Besides this, analyst at Fortune Business Insights™ says, “The increasing patient population and the rising demand for inhalers are encouraging companies to set up new manufacturing units. This is further expected to drive the overall market in the forecast period.”  On the flipside, lack of awareness about inhalers along with their usage, especially amongst the older population may cause hindrance to the overall market. Nevertheless, the rising awareness about the benefits of DPIs and MDIs is expected to help increase their popularity in the market. This, as a result, will give significant impetus to the market in the long run.  Regional Analysis  Europe to Dominate Owing to Rising Prevalence of Asthma   Geographically, the global market is categorized into North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa. Among these, Europe is holding the largest share with a nasal drug delivery technology market revenue of USD 21.1 billion in 2018. This dominance is attributable to the increasing prevalence of asthma, coupled with the rise in awareness about nasal sprays and their benefits. Besides this, there is the rising popularity of inhalers in developing nations of this region, thereby boosting the regional market.   Apart from this, Asia Pacific market share is likely to attract significant Nasal Drug Delivery Market share owing to the rise in awareness campaigns about the use of inhalers and its benefits. Moreover, biopharma companies are utilizing novel technologies for introducing MDI and DPI into the regional market for higher revenue generation during the forecast period.  Quick Buy -  Nasal Drug Delivery Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100415  Competitive Landscape –Demand for Nasal Drug Delivery Products to Fuel as Companies Focus on Launching Eco-friendly Inhalers   Manufacturers of the nasal drug delivery devices are focusing on new product launches to stand out in the market competition and are therefore investing huge sums into research and development for the same. In addition to this, companies are trying to launch environment-friendly inhalers for COPD and asthma patients. They are also promoting advanced technologies by introducing software and advanced services for enhanced user experience. Most of the startup companies in this market are trying to implement applications of agglomerated vesicle technology, particle engineering, nanotechnology, and others for delivering medications to COPD and asthma patients.  List of the Key Companies Operating in the Nasal Drug Delivery Technology Market are:  Consort Medical plc. (United Kingdom)Teva Pharmaceutical Industries Ltd.H&T Presspart Manufacturing Ltd.3MGOFIRE INC.NemeraAptarGroup, Inc. (United States)Vectura Group plc (United Kingdom)Others  Noteworthy Industry Development of Pulmonary Drug Delivery Devices Market Include:  December 2019 – An environment-friendly MDI inhaler was launched at the United Nations Climate Change Conference by Chiesi for COPD and Asthma patients. An investment plan worth USD 382.76 million was made by the company for five years to launch the new product in the market. The company also aims to reduce the overall carbon footprint of MDI by 90%.  Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/nasal-drug-delivery-market-100415  Detailed Table of Content:  Introduction  Research ScopeMarket SegmentationResearch MethodologyDefinitions and Assumptions  Executive SummaryMarket Dynamics  Market DriversMarket RestraintsMarket Opportunities   Key Insights  New Product Launch Pipeline AnalysisTechnological Advancements in the Nasal Drug Delivery MarketPrevalence of Disease IndicationsKey Industry Developments - Mergers, Acquisitions, and Partnerships  Global Nasal Drug Delivery Market Analysis, Insights and Forecast, 2015-2026   Key Findings / SummaryMarket Analysis, Insights and Forecast – By Type  Dry Powder Inhalers (DPI)Metered Dose Inhalers (MDIs)Nebulizers  Market Analysis, Insights and Forecast – By Application  AsthmaChronic Obstructive Pulmonary Disease (COPD)Others  Market Analysis, Insights and Forecast – By Distribution Channel  Hospital PharmaciesRetail PharmaciesOnline Pharmacies  Market Analysis, Insights and Forecast – By Geography  North AmericaEuropeAsia pacificLatin AmericaMiddle East & Africa      TOC Continued….!!!  Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/nasal-drug-delivery-market-100415Have a Look at Related Reports:  Connected Drug Delivery Devices Market Size, Share & Industry Analysis, By Type (Injectable Devices and Inhalation Devices & Others) By Technology (Bluetooth, NFC, and Others) By End User (Homecare Settings and Hospitals) and Regional Forecast, 2019-2026  Injectable Drug Delivery Market Size, Share and Global Trend By Device Type (Conventional Injectable, Pre-filled Syringes, Auto-injectors, Pen-injectors, Others), By Application (Autoimmune Disorders, Diabetes, Pain Management, Aesthetic Treatments, Others), By Route of Administration (Subcutaneous, Intravenous, Intramuscular, Others), By End-User (Hospitals, Home Care Settings, Clinics, Others) and Geography Forecast till 2026  Transdermal Drug Delivery System Market Size, Share & Industry Analysis, By Type (Patches, Gels), By Application (Pain Management, Cardiovascular Diseases, Central Nervous System Diseases, Others), By End User (Hospitals, Clinics, Home Care Settings, Others) and Regional Forecast, 2019-2026  Needle-free Drug Delivery Technology Market Size, Share and Global Trend By Product (Inhaler, Jet Injector, Novel Needles, Transdermal Patch), By Application ( Vaccine Delivery, Pain Management, Insulin Delivery), By End Users (Hospitals & Clinics, Homecare Settings, Research Laboratories, Academics), and Geography Forecast till 2026  About Us:  Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.  Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.  At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.  Contact Us:  Fortune Business Insights™ Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India.  Phone:US :+1 424 253 0390UK : +44 2071 939123APAC : +91 744 740 1245Email: sales@fortunebusinessinsights.comFortune Business Insights™LinkedIn | Twitter | Blogs  Press Release: https://www.fortunebusinessinsights.com/press-release/nasal-drug-delivery-market-9633  

, <br>GlobeNewswire